FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/02/031146 [Registered on: 09/02/2021] Trial Registered Prospectively
Last Modified On: 26/03/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Biological
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical study to see the effect of some Ayurvedic formulation in the form of nasal administration in the treatment of Vataj Shirashoola w.r.t. Headache 
Scientific Title of Study   Comparative clinical trial to evaluate the efficacy of Baladi Ghritamanda Nasya and Ksheerabala Taila Nasya in the Management of Vataj Shirashoola 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vd Mahejabeen Munir Jikare 
Designation  M.S.Scholar Shalakyatantra 
Affiliation  Sumatibhai Shah Ayurved Mahavidyalaya 
Address  OPD No.09, Department of Shalakyatantra, Sane Guruji Arogya Kendra, Malwadi road, Hadapsar, Pune
Department of Shalakyatantra, Sane guruji Arogya Kendra, Malwadi road, Hadapsar
Pune
MAHARASHTRA
411028
India 
Phone  9623658384  
Fax    
Email  mjikare@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Nilakshi Pradhan 
Designation  HOD and Professor of Shalakya tantra Department 
Affiliation  Sumatibhai Shah Ayurved Mahavidyalaya 
Address  OPD No.09, Department of Shalakyatantra, Sane Guruji Arogya Kendra, Malwadi road, Hadapsar, Pune
Department of Shalakyatantra, Sane guruji Arogya Kendra, Malwadi road, Hadapsar
Pune
MAHARASHTRA
411028
India 
Phone  9423580963  
Fax    
Email  drnspradhan@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Vd Mahejabeen Munir Jikare 
Designation  M. S. Scholar Shalakyatantra (Ayurved) 
Affiliation  Sumatibhai Shah Ayurved Mahavidyalaya 
Address  OPD No.09, Department of Shalakyatantra, Sane Guruji Arogya Kendra, Malwadi road, Hadapsar, Pune
Department of Shalakyatantra, Sane guruji Arogya Kendra, Malwadi road, Hadapsar
Pune
MAHARASHTRA
411028
India 
Phone  9623658384  
Fax    
Email  mjikare@gmail.com  
 
Source of Monetary or Material Support  
Department of Shalakyatantra, Sane guruji Arogya Kendra, Malwadi road, Hadapsar,Pune 
 
Primary Sponsor  
Name  Sane guruji Arogya Kendra 
Address  Sane Guruji Arogya Kendra, Malwadi road, Hadapsar, Pune 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Vd Mahejabeen Munir Jikare  Sane Guruji Arogya Kendra, Malwadi road, Hadapsar, Pune 411028  OPD No.09, Department of Shalakyatantra, Sane Guruji Arogya Kendra, Malwadi road, Hadapsar, Pune
Pune
MAHARASHTRA 
9623658384

mjikare@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Intitutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  (1) ICD-10 Condition: R51||Headache, (2) ICD-10 Condition:R51||Headache. Ayurveda Condition: VATAJA-SIROROGAH,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Baladi Ghritamanda  It is a formulation of Ayurvedic herbs prepared in the form of ghritamanda for nasal administration(nasya) having Bala and Bilva churna,Goghrita,Ghritamanda ,godugdha(cows milk) which will be administered for nasya 2 drops in each nostril once a day for 7 days. 
Comparator Agent  Ksheerabala Taila  It is formulation of ayurvedic herbs prepared in the form of Taila for nasal administration (nasya) having combination of Balamula,Godugdha (cows milk),Tila Taila which will be administered for nasya 2 drops in each nostril once a day for 7 days 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1)patients suffering from symptoms of Vataj Shiashoola i.e. Shankha Ativedana, Bhru Ativedana, Lalat Ativedana
2)patients of age group 20 to 60 yrs
3)patients of eiter gender will be included in the study
4)patients yogya for Nasyakarma 
 
ExclusionCriteria 
Details  1)patients suffering from Sinusitis,systemic disorder like Hypertension, Diabetes,
2)Secondary Headache caused by Meningitis, Tumour, Encephalitis
3)Pregnancy and Lactation 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
A clinical study to evaluate efficacy of Baladi Ghritamanda Nasya in Vataj Shirashoola w.r.t. Headache.
Subjective Parameters(by using grades and Visual analogue Scale)-Shankha Ativedana,Bhru Ativedana,Lalat Ativedana
Other subjective parameters-Severity of headache, Frequency of headache,Duration of headache 
The drug will be given for 7 days.patient will be assessed before and after treatment.Total duration of study will be 18 months. 
 
Secondary Outcome  
Outcome  TimePoints 
Comparision between efficacy of Baladi Ghritamanda Nasya and Ksheerabala Taila Nasya in Vataj Shirashoola w.r.t. Headahe.  Total duration of study will be 18 months 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/03/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is open labelled randomised comparative clinical trial to evaluate the effect of Baladi Ghritamanada Nasya 2 drops in each nostril once a day for 7 days in comparison with Ksheerabala Taila Nasya given same as Baladi Ghritamanda Nasya in Vataj Shirashoola w.r.t. Headache. The primary outcome will be effect of Baladi Ghritamanda Nasya and Secondary outcome will be comparison between trial drug and control drug in the management of Vataj Shirashoola w.r.t. Headache. 
Close